Stock market week-in-review for 5 large GI companies — Aug. 7-11

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of Aug. 7 to Aug. 11, 2017.

Note: This data was compiled using Google Finance.

1. Allergan Pharmaceuticals

Opened: $242.55 on Aug. 7
Peaked: $245.23 on Aug. 8
Closed: $232.88 on Aug. 11
Percent change between Aug 7 to Aug. 11: -3.98 percent

2. Exact Sciences Corp.

Opened: $38.69 on Aug. 7
Peaked: $39.75 on Aug. 7
Closed: $37.76 on Aug. 11
Percent change between Aug 7 to Aug. 11: -2.40 percent

3. Johnson & Johnson

Opened: $133.11 on Aug. 7
Peaked: $134.41 on Aug. 11
Closed: $133.27 on Aug. 11
Percent change between Aug 7 to Aug. 11: 0.12 percent

4. Synergy Pharmaceuticals

Opened: $3.73 on Aug. 7
Peaked: $3.86 on Aug. 8
Closed: $2.96 on Aug. 11
Percent change between Aug 7 to Aug. 11: -20.64 percent

5. Valeant Pharmaceuticals

Opened: $15.09 on Aug. 7
Peaked: $16.89 on Aug. 8
Closed: $13.87 on Aug. 11
Percent change between Aug 7 to Aug. 11: -8.08 percent

More articles on gastroenterology: 
GI center to know: GastroIntestinal Health
Stock market week-in-review for 4 large ASC chains — Aug. 7-11
GI leader to know: Dr. Neil Price of GastroIntestinal Health

© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months